[{"from": "human", "value": "Please give me some details about this molecule. [C][=C][C][=Branch2][Branch2][#Branch1][=C][Branch2][Branch1][#Branch1][C][=C][Ring1][=Branch1][C][C][C][=Branch1][C][=O][N][C][C][C][C][C][C][=Branch1][C][=O][N][C][C][C][C][C@@H1][Branch1][=Branch1][C][=Branch1][C][=O][O][N][C][=Branch1][C][=O][N][C@@H1][Branch1][Branch2][C][C][C][=Branch1][C][=O][O][C][=Branch1][C][=O][O][C][N][Branch2][Ring2][C][C][C][N][Branch2][Ring1][=Branch1][C][C][=C][Branch1][S][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][C][C][=Branch1][C][=O][O][O][C][C][=Branch1][C][=O][O][C][C][=Branch1][C][=O][O][O]"}, {"from": "gpt", "value": "The molecule is an unlabeled radiotracer composed of the human prostate specific membrane antigen (PSMA)-targeting ligand and linked to the acyclic radiometal chelator N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl] ethylenediamine-N,N'-diacetic acid (HBED-CC), that may potentially be used to prevent or reduce salivary gland toxicities of PSMA-targeted radionuclides. Upon administration of gozetotide into the salivary gland, gozetotide may selectively decrease salivary uptake of systemically administered PSMA-targeted radionuclides. This may reduce the salivary gland toxicities of these agents including salivary gland hypofunction and xerostomia."}]